Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Stromal contribution to the colorectal cancer transcriptome.

Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, Inghirami G, Trusolino L, Fekete Z, De Ridder M, Cassoni P, Storme G, Bertotti A, Medico E.

Nat Genet. 2015 Feb 23. doi: 10.1038/ng.3224. [Epub ahead of print]

PMID:
25706627
2.

Quality Assurance of a 50-kV Radiotherapy Unit Using EBT3 GafChromic Film: A Feasibility Study.

Steenbeke F, Gevaert T, Tournel K, Engels B, Verellen D, Storme G, Ridder M.

Technol Cancer Res Treat. 2015 Jan 9. pii: 1533034614565910. [Epub ahead of print]

PMID:
25575576
3.

Analysis of the targeting uncertainty of a stereotactic frameless radiosurgery technique for arteriovenous malformation.

Steenbeke F, Gevaert T, Engels B, Poels K, D'Haens J, Van Tussenbroek F, Verellen D, Storme G, De Ridder M.

Radiother Oncol. 2014 Dec;113(3):371-3. doi: 10.1016/j.radonc.2014.10.003. Epub 2014 Oct 29.

PMID:
25454170
4.

Improving the intra-fraction update efficiency of a correlation model used for internal motion estimation during real-time tumor tracking for SBRT patients: fast update or no update?

Poels K, Depuydt T, Verellen D, Gevaert T, Dhont J, Duchateau M, Burghelea M, Boussaer M, Steenbeke F, Collen C, Engels B, Storme G, De Ridder M.

Radiother Oncol. 2014 Sep;112(3):352-9. doi: 10.1016/j.radonc.2014.09.007. Epub 2014 Oct 24.

PMID:
25443498
5.

Multi-institutional Feasibility Study of a Fast Patient Localization Method in Total Marrow Irradiation With Helical Tomotherapy: A Global Health Initiative by the International Consortium of Total Marrow Irradiation.

Takahashi Y, Vagge S, Agostinelli S, Han E, Matulewicz L, Schubert K, Chityala R, Ratanatharathorn V, Tournel K, Penagaricano JA, Florian S, Mahe MA, Verneris MR, Weisdorf DJ, Corvo R, Dusenbery KE, Storme G, Hui SK.

Int J Radiat Oncol Biol Phys. 2014 Oct 30. pii: S0360-3016(14)04107-8. doi: 10.1016/j.ijrobp.2014.09.014. [Epub ahead of print]

PMID:
25442340
6.

Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer.

Van den Begin R, Engels B, Gevaert T, Duchateau M, Tournel K, Verellen D, Storme G, De Ridder M.

Radiother Oncol. 2014 Nov;113(2):235-9. doi: 10.1016/j.radonc.2014.11.005. Epub 2014 Nov 28.

PMID:
25441611
7.

Breast conserving treatment for breast cancer: dosimetric comparison of sequential versus simultaneous integrated photon boost.

Van Parijs H, Reynders T, Heuninckx K, Verellen D, Storme G, De Ridder M.

Biomed Res Int. 2014;2014:827475. doi: 10.1155/2014/827475. Epub 2014 Aug 4.

8.

Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.

Collen C, Christian N, Schallier D, Meysman M, Duchateau M, Storme G, De Ridder M.

Ann Oncol. 2014 Oct;25(10):1954-9. doi: 10.1093/annonc/mdu370. Epub 2014 Aug 11.

PMID:
25114022
9.

Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review.

Depuydt T, Poels K, Verellen D, Engels B, Collen C, Buleteanu M, Van den Begin R, Boussaer M, Duchateau M, Gevaert T, Storme G, De Ridder M.

Radiother Oncol. 2014 Sep;112(3):343-51. doi: 10.1016/j.radonc.2014.05.017. Epub 2014 Jul 18.

PMID:
25049177
10.

Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer.

Engels B, Soete G, Gevaert T, Storme G, Michielsen D, De Ridder M.

Radiother Oncol. 2014 Apr;111(1):106-9. doi: 10.1016/j.radonc.2014.02.009. Epub 2014 Mar 13.

PMID:
24631146
11.

Reply to the letter to the editor 'Are male gender and nonadenocarcinoma histology valid prognostic factors for breast cancer?' by Eren et al.

de Vin T, Engels B, Gevaert T, Storme G, De Ridder M.

Ann Oncol. 2014 Apr;25(4):911-2. doi: 10.1093/annonc/mdu046. Epub 2014 Mar 7. No abstract available.

PMID:
24608190
12.

Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery.

Van Parijs H, Reynders T, Heuninckx K, Verellen D, Storme G, De Ridder M.

Radiat Oncol. 2014 Jan 27;9:36. doi: 10.1186/1748-717X-9-36.

13.

Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival.

de Vin T, Engels B, Gevaert T, Storme G, De Ridder M.

Ann Oncol. 2014 Feb;25(2):467-71. doi: 10.1093/annonc/mdt537. Epub 2013 Dec 18.

14.

Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.

Engels B, Platteaux N, Van den Begin R, Gevaert T, Sermeus A, Storme G, Verellen D, De Ridder M.

Radiother Oncol. 2014 Jan;110(1):155-9. doi: 10.1016/j.radonc.2013.10.026. Epub 2013 Nov 12.

PMID:
24239243
15.

A complementary dual-modality verification for tumor tracking on a gimbaled linac system.

Poels K, Depuydt T, Verellen D, Engels B, Collen C, Heinrich S, Duchateau M, Reynders T, Leysen K, Boussaer M, Steenbeke F, Tournel K, Gevaert T, Storme G, De Ridder M.

Radiother Oncol. 2013 Dec;109(3):469-74. doi: 10.1016/j.radonc.2013.10.005. Epub 2013 Nov 14.

PMID:
24238982
16.

Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy.

Takahashi Y, Verneris MR, Dusenbery KE, Wilke CT, Storme G, Weisdorf DJ, Hui SK.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):832-9. doi: 10.1016/j.ijrobp.2013.07.017. Epub 2013 Sep 5.

17.

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.

Norkus D, Karklelyte A, Engels B, Versmessen H, Griskevicius R, De Ridder M, Storme G, Aleknavicius E, Janulionis E, Valuckas KP.

Radiat Oncol. 2013 Sep 4;8:206. doi: 10.1186/1748-717X-8-206.

18.

Evaluation of the clinical usefulness for using verification images during frameless radiosurgery.

Gevaert T, Boussaer M, Engels B, Litré CF, Prieur A, Wdowczyk D, Verellen D, Storme G, D'Haens J, Colin P, De Ridder M.

Radiother Oncol. 2013 Jul;108(1):114-7. doi: 10.1016/j.radonc.2013.04.018. Epub 2013 May 25.

PMID:
23714654
19.

Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury.

Cetin IA, Ates R, Dhaens J, Storme G.

Strahlenther Onkol. 2012 Dec;188(12):1133-8. doi: 10.1007/s00066-012-0180-6. Epub 2012 Nov 7.

PMID:
23128895
20.

Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.

Versmessen H, Vinh-Hung V, Van Parijs H, Miedema G, Voordeckers M, Adriaenssens N, Storme G, De Ridder M.

BMC Cancer. 2012 Oct 25;12:495. doi: 10.1186/1471-2407-12-495.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk